Reading this on a mobile device? Try our optimized mobile version here:

March 22, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  • Genetic technique may open new doors to fighting dengue fever
    Scientists at Virginia Tech have developed a method for deleting genes in the mosquito that spreads the dengue virus. The technology involves two engineered proteins in a class called transcription activator-like effector nucleases. Previous consideration of genetic dengue controls involved the addition of genes. "This technology allows us to pursue the same goals, namely, the generation of pathogen-resistant mosquitoes, through subtraction," an entomologist said. NBC News/Cosmic Log blog (3/21) LinkedInFacebookTwitterEmail this Story
Clinical Research: Understanding the Methodology Toolbox
Clinical Research: Understanding the Methodology Toolbox compiles articles of evidence-based research for use as an educational resource for those involved in clinical research, healthcare professionals and trainees in transfusion medicine and other medical specialties. Now in the AABB Marketplace.

  Science & Health 
  • PRP therapy relieves elbow pain better than other care in study
    Platelet-rich plasma therapy may relieve pain associated with chronic tennis elbow up to six months following the treatment, according to a study of 230 patients reported at an orthopedic surgeons' meeting. Twelve weeks after treatment, patients who received the treatment reported 55% improvement in pain scores, compared with about 47% for patients who received standard treatment. At six months, platelet treatment was associated with 72% improvement in pain scores, compared with about 56% in the comparison group. (3/21) LinkedInFacebookTwitterEmail this Story
  • Calif. institute grants $26M for stem cell research
    The California Institute for Regenerative Medicine awarded Cellular Dynamics International $16 million to develop three induced pluripotent stem cell lines for each of 3,000 samples from ill and healthy donors. The institute also will give $10 million to the Coriell Institute for Medical Research to create a biobank for the cell lines and a repository for the samples. American City Business Journals/Philadelphia (3/21) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • Budget cut could jeopardize poor's access to HIV/AIDS drugs
    The House and the Senate so far have failed to earmark $35 million in funding for state AIDS Drug Assistance Programs, which endangers their capacity to provide access to treatments for almost 8,000 patients with HIV, advocates said. Some states, including Florida and Illinois, may have to stop giving drugs, AIDS Institute Deputy Executive Director Carl Schmid said. Blog (3/20) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • EU approves bleeding control device from iTraumaCar
    Canadian firm iTraumaCar has received European approval for its iTClamp Hemorrhage Control System, which was developed by a retired Canadian military surgeon to address severe bleeding from open wounds, particularly when drugs and tourniquets are not adequate. The system could be used by civilian first responders and on the battlefield. (3/21) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • States take action on compounding pharmacies
    State scrutiny of specialty pharmacies is increasing in response to last fall's deadly meningitis outbreak tied to tainted steroids from the New England Compounding Center. States are considering making pharmacies get special permits to mix sterile drugs, and surprise inspections are being conducted. Virginia and Maryland are among a dozen states considering tighter licensing requirements. New York regulators issued a sales moratorium for one of the nation's biggest compounders, while Iowa's pharmacy board hopes to inspect more than 600 out-of-state compounders that supply medicines to the state. The Washington Post (3/20) LinkedInFacebookTwitterEmail this Story
  • CMS announces MU targets for hospitals, physician practices for 2013
    CMS said at the HIMSS13 conference that it anticipates 80% of qualified hospitals and 50% of qualified physician practices will become meaningful users this year. Acting CMS Administrator Marilyn Tavenner said 2013 would be "busy," with a focus on education. "We're going to spend a lot more time with physicians -- helping physicians learn, and helping physicians work with their current vendors to make things a little easier for them," Tavenner said. Family Practice News (3/19) LinkedInFacebookTwitterEmail this Story
  Association News 
  • RBC Transfusion Data Card now available in AABB Marketplace
    The RBC Transfusion Data Card is available for purchase in the AABB Marketplace. The data card is a pocket-sized reference guide that summarizes red blood cell transfusion guidelines for treating adults and pediatric patients. Indications, contraindications and key points on administration are included on the card. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Associate Medical DirectorBloodCenter of WisconsinUS - WI - Milwaukee
Director, Quality (CTS-Chicago)Blood Systems, Inc.US - IL - Rosemont
Director, Community Center IIUnited Blood ServicesUS - SD - Rapid City
Quality SpecialistBlood Systems, Inc.US - AZ - Scottsdale
Quality Specialist (BCP)Blood Systems, Inc.US - CA - San Francisco
Laboratory SupervisorBaxter HealthcareUS - AL - Hoover
Click here to view more job listings.

If we were all given by magic the power to read each other's thoughts, I suppose the first effect would be to dissolve all friendships."
--Bertrand Russell,
British philosopher, mathematician and historian

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information